Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) (PfEMP1)

Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a key virulence factor expressed on the surface of erythrocytes infected by the malaria parasite. It mediates the adhesion of infected red blood cells (iRBCs) to various host receptors, a process known as cytoadherence, which prevents the clearance of parasites by the spleen (Wahlgren et al., 2017). A specific form of this adhesion, termed rosetting, involves the binding of an iRBC to multiple uninfected red blood cells (uRBCs), forming clusters that obstruct microvascular blood flow (Rowe et al., 2009). The rosetting interface is primarily mediated by the N-terminal Duffy-binding-like (DBL1α) domain of PfEMP1, which interacts with host receptors such as Complement Receptor 1 (CR1), ABO blood group antigens, and heparan sulfate (Vigan-Womas et al., 2012). Rosetting is strongly correlated with severe clinical manifestations of malaria, including cerebral malaria and severe anemia, making the PfEMP1-mediated rosetting interface a high-priority target for therapeutic intervention. Current drug development efforts focus on small molecules, heparin derivatives like sevuparin, and monoclonal antibodies designed to disrupt these adhesive interactions and restore microcirculatory function (Leitgeb et al., 2011).

Other names

Erythrocyte membrane protein 1Var proteinPfEMP-1Antigenic variation proteinRosetting ligand

Competitive inhibition of the DBL1α domain binding to host receptors (e.g., CR1, Heparan Sulfate) to disrupt the formation of erythrocyte clusters (rosettes) and prevent microvascular sequestration.